China’s struggle to recover from the shock of COVID-19 in 2024 laid bare long-standing vulnerabilities in its economy.

Recent health developments include a new injectable cancer drug by Bristol Myers Squibb, a revived lawsuit against Novartis ...

WHILE much of the focus in terms of foreign stories in 2025 will stem from Trump, and the conflicts in Ukraine and the Middle East, other major events should also be on our radar. Among other more ...

Robert Redfield, who led the CDC during Trump's first term, said "it's possible" that U.S. intelligence agencies were helping ...

INR:4140. voter id update Novartis TQJ230 injection has been approved for clinical trials in China and targeted antisense drugs have been launched in China The Un ...

sukuna true form Sinovac Biotech's COVID-19 vaccine application for listing accepted by NMPA R&D Daily丨Pfizer/BioNTech COVID-19 vaccine first received emergency use authorization in the UK UCB's ...

Sweden, Lithuania and the Czech Republic have not been granted visa-free access by Beijing, with analysts citing Taiwan among likely factors.

Recent health news includes the FDA's approval of an injectable version of Opdivo, a revived lawsuit against Novartis for ...

“The growing middle-/high-income population in China will continue to fuel demand for upscale hotels,” the UBS report says. “Currently, both the number of upscale and luxury hotel guest rooms and the ...

The suppression of the lab theory proves the ultimate fallacy of censorship. Throughout history, censorship has never ...

Discover why Star Bulk Carriers' stock dropped 40% but still holds strong long-term potential in the shipping market. Click ...